RA Capital Management »

Jatt Ii Acquisition Corp shares owned by RA Capital Management

Quarter-by-quarter ownership of Jatt Ii Acquisition Corp shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Jatt Ii Acquisition Corp

Tip: Access up to 7 years of quarterly data

All positions including Jatt Ii Acquisition Corp held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jatt Ii Acquisition Corp by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.7M 500k 11.36

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Jatt Ii Acquisition Corp

Dr. Jeffrey R. Jay, M.D.
Jupiter Topco
Balyasny Asset Management
RA Capital Management
ADAR1 Capital Management
Franklin Resources
Atika Capital Management
Citadel Advisors
Farallon Capital Management
Braidwell
Nantahala Capital Management
Affinity Asset Advisors
TCG Crossover Management
Spruce Street Capital
Millennium Management

View all funds holding Jatt Ii Acquisition Corp